Novartis wins Gilenya reprieve as judge blocks generics, for now

The judge said letting generics makers sell their versions before the
patent dispute was decided would damage the Swiss drugmaker more than
those wanting a piece of Gilenya's market.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-wins-gilenya-reprieve-as-judge-blocks-generics-for-now/articleshow/69947011.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation